Pharma Research

The state of global clinical research trials

New technologies and changing economic conditions have triggered a number of changes in the pharmaceuticals, life-sciences and biotech sectors. Increasing global sales of life sciences products and growing demand for biologics drugs present drug-industry companies with a host of opportunities. However, the mandate for clinical trials has led to considerable inflation in their R&D expenditure. The resolution lies in using emerging markets as an alternative to conduct these trials.

Despite inefficiencies in logistics issues causing delays in customs clearance to deliver materials securing depot facilities in-country for just-in-time delivery that this option entails, clinical testing offshoring appears to be a viable option. Thanks to new technologies, cloud and social media/online portals, the pharmaceuticals, life-sciences and biotech sectors can make the most of the emerging opportunities. This joint research by UBM TechWeb and Wipro gives some more insights and statistics on this interesting new trend.

Add your comment

Name	:

Email	:

Comments	:

Enter Captcha	:	Enter the words above: Enter the numbers you hear: Try diffrent words What is? Incorrect please try again

You should also do your due diligence before working with Clinical Investigator Site. Here are a couple of points you should ask to make sure they have quality systems in place. 1) How many studies have they participated in. 2) Do they have in place. 3) How type of training program they have in place.
Linda 88 Days ago